To investigate the effects of treatment with rosuvastatin and atorvastatin on serum endothelin-1 (ET-1) and asymmetrical dimethylarginine (ADMA) in elderly patients with coronary artery disease combined with hyperlipidemia. This evidence concerns the gene EDN1 and coronary artery disorder.